AGGAME

¸ÎÆÆËéÔÚÖÖÖÖ¸¹²¿ËðÉËÖÐÔ¼Õ¼15%×óÓÒ¡£Ò»Ñùƽ³£À´Ëµ£¬ÓÒ¸ÎÆÆËé½Ï×ó¸ÎΪ¶à¡£¸ÎλÓÚÓÒ²àëõϺͼ¾ÀßÉîÃæ£¬ÊÜÐØÀªºÍëõ¼¡±£»¤£¬Ò»Ñùƽ³£²»Ò×ËðÉË£¬µ«ÓÉÓÚ¸ÎÔàÖʵØųÈõ£¬Ñª¹Ü¸»ºñ£¬²¢ÇÒ±»ÖÜΧµÄÈÍ´øÀο¿£¬Òò¶øÒ²ÈÝÒ×Êܵ½ÍâÀ´±©Á¦»òÈñÆ÷´ÌÉ˶øÒýÆðÆÆËé³öѪ¡£

±©·¢ÐÔ¸ÎÑ×°üÀ¨ÈýÖÖÌåÕ÷£º1ËÄ»·ËØÖÂÖж¾ÐÔ¸ÎÑ×£¬·þÓôó×ÚËÄ»·ËØ×忹ÉúËØ¿ÉÖ¼±ÐÔÖ¬·¾¸Î,µ«ÒÔÔи¾Îª¶à;2ÈÑÉï¼±ÐÔÖ¬·¾¸Î£¬»¼Õ߶àΪ20¡«30ËêµÄ³õ²ú¸¾,;3Reye×ÛºÏÕ÷(ÄÔ²¡Ö¬·¾¸Î×ÛºÏÕ÷)£¬ÏµÖ¸²¡¶¾,Öж¾¼°´úлÕÏ°­µÈËùÖÂÄÔË®Ö×¼°¸Î,ÉöµÈÔàÆ÷Ö¬·¾³Á»ý¡£

ƾ֤ÁÙ´²Ìص㣺ԭÓÐÂýÐÔHBVѬȾ£¬½üÆÚÄÚ·ºÆð×Å×´£¬¸Î¹¦Ð§Òì³£;»òÔ­ÓÐÂýÐÔÔ˶¯ÐÔ¸ÎÑס¢¸ÎÓ²»¯½üÆÚ²¡Çé¶ñ»¯ÇÒÖÎÁÆЧ¹û²»Á¼Õß£¬¾ùӦ˼Á¿µ½ÖصþѬȾÆäËû¸ÎÑײ¡¶¾µÄ¿ÉÄÜ£¬Ó¦ÊµÊ±¾ÙÐÐÓйز¡Ô­Ñ§Ö¸±ê¼ì²â¡£

¸Î·Î×ÛºÏÕ÷(hepatopulmonary syndrome£¬HPS)ÊÇÓÉÖÖÖÖ¼±ÂýÐԸβ¡²¢·¢µÄ·ÎÔàѪ¹ÜÀ©ÕźͶ¯ÂöÑõÏàÖúÓÃÒì³£ÒýÆðµÄµÍÑõѪ֢¡£ÊµÖÊÉÏÊÇÔ­·¢ÐԸβ¡¡¢·ÎÄÚѪ¹ÜÀ©ÕźͶ¯ÂöÑõºÏȱ·¦Ëù×é³ÉµÄÈýÁªÕ÷¡£

ÒÒÐ͸ÎÑײ¡¶¾ÊÇË«Á´»·×´DNA²¡¶¾£¬¸Ã²¡¶¾ÓÐ3¸öÖ÷ÒªµÄ¿¹Ô­£¬°üÀ¨Íâò¿¹Ô­(HBsAg)¡¢½¹µã¿¹Ô­(HBcAg)¼°e¿¹Ô­¡£³ýÁËÒýÆð¸ÎÑ×Íâ£¬ÒÒÐ͸ÎÑײ¡¶¾Ñ¬È¾»¹¿ÉÒýÆð¶àÖÖ·çʪÐÔ¼²²¡£¬°üÀ¨½á½ÚÐԶදÂöÑס¢Æ¤¼¡Ñ×¼°¶à¼¡Ñס¢À×ŵ֢µÈ£¬µ«³£¼ûµÄΪѪÇ岡ÑùÊàŦÑ×ƤÑ××ÛºÏÕ÷¡£

¸ÎÎÁÓÖ³ÆÎÁ»Æ¡¢Ò߻ơ£¸ÎÎÁÃû³ö¡¶Ã÷Ò½ÔÓ×Å¡·¡£ÒòÆä·¢²¡¼±£¬¡¶ÖԴºòÂÛ#8226;»Æ²¡Öîºò¡·ÓÖ³Æ֮Ϊ¼±»Æ£º¡°Æ¢Î¸ÓÐÈÈ£¬¹ÈÆøÓôÕô£¬ÓÉÓÚÈȶ¾Ëù¼Ó£¬¹Ê×äÈ»·¢»Æ£¬ÐÄÂúÆø´­£¬ÃüÔÚö®Ê±£¬¹ÊÔƼ±»ÆÒ²¡£¡±¡¡¡¡±¾²¡Ï൱ÓÚÎ÷ҽѧËù˵µÄ¼±ÐÔ²¡¶¾ÐÔÖØÖ¢¸ÎÑס£

ÏÈÌìÐÔ¸ÎÄÒÖ×Î޺ϲ¢Ö¢Õß£¬×ÝÈ»ÄÒÖ׺ܴó£¬Í¨³£Ò²²»Ó°Ïì¸ÎÔ๦Ч£¬Òò´Ë£¬ÊµÑéÊÒ¼ì²éºÜÉÙÓÐÑôÐÔЧ¹û¡£µ±·ºÆðºÏ²¢Ö¢Ê±£¬²¡ÈË¿ÉÌåÏÖΪ¸ÎÔ൨ºìËØ¡¢×ª°±Ã¸¡¢¼îÐÔÁ×Ëáø¡¢×ªëÄøÉý¸ß;ºÏ²¢Ñ¬È¾µÄ²¡ÈË¿É·ºÆðѪ°×ϸ°û¼°·ÖÀàÉý¸ßµÈÌåÏÖ¡£

µ¨ÄÒ-½á³¦¸ÎÇúÕ³Á¬×ÛºÏÕ÷(Cholecysto-hepatic Flexure Adhesion Syndrome)ÓÚ1930ÄêÓÉVerbrycheÏÈÐÎò¡£¹ÊÓÖ³ÆVerbrycke×ÛºÏÕ÷£¬µ¨ÄÒ¸ÎÇúÕ³Á¬×ÛºÏÕ÷¡£

ÏÈÌìÐÔ·ÇÈÜѪÐÔ»Æðã(Gilbert×ÛºÏÕ÷)£¬ÊÇÒ»×é×ۺϵIJ¡Ö¢£¬Ïµ1092Äê·¨¹úҽʦGilbertÏȱ¨¸æ£¬Îª·ÇÈÜѪÐÔ¡¢·ÇÍŽáÐÔµ¨ºìËØѪ֢ËùÖµĻÆðã¡£ÏÈÌìÐÔ»¼Õß¼Ò×åÖÐÓÐ25%¡«50%µÄÈËÓд˲¡£¬Îª³£È¾É«ÌåÏÔÐÔÒÅ´«²¡¡£

ÈÑÉïÆÚ¼±ÐÔÖ¬·¾¸ÎÓֳƲú¿Æ¼±ÐÔ¼ÙÐÔ»ÆÉ«¸ÎήËõ£¬ÊÇÈÑÉïÍíÆÚÌØÓеÄÖÂÃüÐÔÉÙ¼û¼²²¡¡£¸Ã²¡Æ𲡼±Öè£¬²¡Çéת±äѸËÙ£¬ÁÙ´²ÌåÏÖÓ뱩·¢ÐÔ¸ÎÑ×ÏàËÆ£¬¼ÈÍùÎÄÏ×±¨µÀĸ¶ùéæÃüÂÊ»®·ÖΪ75%ºÍ85%£¬µ«ÈçÄÜ×öµ½ÔçÆÚÕï¶Ï¡¢ÔçÆÚÖÎÁÆ¡¢ÊµÊ±ÖÕÖ¹ÈÑÉï£¬¿É½µµÍĸÇ×éæÃüÂÊ£¬Ó¤¶ùéæÃüÂʿɽµÖÁ58.3%¡£